个人中心| | 帮助
高级检索
当前位置： 首页 > 详情页

Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons

| 认领 | 导出 |

文献详情

资源类型：
WOS体系：

收录情况： ◇ SCIE ◇ CPCI(ISTP)

作者：
Sun, Hui-Chuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Fan, Jia[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhou, Jian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Chen, Minshan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Liu, Lianxin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Huang, Zhiyong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Wen, Tianfu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Wang, Lu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Wang, Kui[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Xu, Li[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Shi, Ying-Hong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Yang, Xin-Rong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Li, Jun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Gao, Jie[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Bi, Xinyu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Shang, Changzhen[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zheng, Xin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Hong, Zhixian[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Wang, Haiqing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ;
机构： [1]Fudan Univ, Liver Canc Inst, Shanghai, Peoples R China [2]Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China [3]Fudan Univ, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai, Peoples R China [4]Sun Yat Sen Univ, Canc Ctr, Dept Liver Surg, Guangzhou, Peoples R China [5]Univ Sci & Technol China, Affiliated Hosp 1, Hefei, Peoples R China [6]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hepatobiliary Surg, Wuhan, Peoples R China [7]Sichuan Univ, West China Hosp, Dept Liver Surg, Sichuan, Peoples R China [8]Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Sichuan, Peoples R China [9]Shanghai Canc Ctr, Liver Surg Dept, Shanghai, Peoples R China [10]Naval Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg II, Shanghai, Peoples R China [11]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China [12]Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China [13]Peking Univ Peoples Hosp, Dept Hepatobillary Surg, Beijing, Peoples R China [14]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Hepatobiliary Surg, Beijing, Peoples R China [15]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China [16]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [17]Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China [18]Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, Chengdu, Peoples R China
出处：
ISSN：
基金：
Suzhou Zelgen Biopharmaceuticals Co., Ltd.
语种：
外文
被引次数：
WOS：
中科院(CAS)分区：
出版当年[2022]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
最新[2023]版：
大类 | 1 区 医学
小类 | 1 区 肿瘤学
JCR分区：
出版当年[2022]版：
Q1 ONCOLOGY
最新[2023]版：
Q1 ONCOLOGY

影响因子： 最新[2023版] 最新五年平均 出版当年[2022版] 出版当年五年平均 出版前一年[2021版] 出版后一年[2023版]

第一作者：
第一作者机构： [1]Fudan Univ, Liver Canc Inst, Shanghai, Peoples R China [2]Fudan Univ, Zhongshan Hosp, Shanghai, Peoples R China [3]Fudan Univ, Liver Canc Inst, Dept Liver Surg & Transplantat, Shanghai, Peoples R China [4]Sun Yat Sen Univ, Canc Ctr, Dept Liver Surg, Guangzhou, Peoples R China [5]Univ Sci & Technol China, Affiliated Hosp 1, Hefei, Peoples R China [6]Huazhong Univ Sci & Technol, Tongji Hosp, Dept Hepatobiliary Surg, Wuhan, Peoples R China [7]Sichuan Univ, West China Hosp, Dept Liver Surg, Sichuan, Peoples R China [8]Sichuan Univ, West China Hosp, Liver Transplantat Ctr, Sichuan, Peoples R China [9]Shanghai Canc Ctr, Liver Surg Dept, Shanghai, Peoples R China [10]Naval Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Hepat Surg II, Shanghai, Peoples R China [11]Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China [12]Shanghai Tenth Peoples Hosp, Shanghai, Peoples R China [13]Peking Univ Peoples Hosp, Dept Hepatobillary Surg, Beijing, Peoples R China [14]Chinese Acad Med Sci & Peking Union Med Coll, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Dept Hepatobiliary Surg, Beijing, Peoples R China [15]Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Guangzhou, Peoples R China [16]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Peoples R China [17]Peoples Liberat Army Gen Hosp, Med Ctr 5, Beijing, Peoples R China [18]Univ Elect Sci & Technol China, Sichuan Canc Hosp & Inst, Sichuan Canc Ctr, Sch Med, Chengdu, Peoples R China
推荐引用方式(GB/T 7714)：
Sun Hui-Chuan,Fan Jia,Zhou Jian,et al.Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):E16127-E16127.
APA：
Sun, Hui-Chuan,Fan, Jia,Zhou, Jian,Chen, Minshan,Liu, Lianxin...&Wang, Haiqing.(2022).Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA：
Sun, Hui-Chuan,et al."Clinical practice status of the adjuvant therapy in hepatocellular carcinoma (HCC): A survey of Chinese hepatobiliary surgeons".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022):E16127-E16127

资源点击量：43377 今日访问量：0 总访问量：3120 更新日期：2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持：重庆聚合科技有限公司 地址：成都市人民南路四段55号